Veracyte Inc
VCYT
Market Cap$1.79B
Close$
$-5.19
122.2% downside
Current Fair Value
122.2% downsideOvervalued by 122.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.79 Billion |
|---|---|
| Enterprise Value | $1.59 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-0.93 |
| Beta | 2.0 |
| Outstanding Shares | 76,448,070 |
| Avg 30 Day Volume | 771,488 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -26.24 |
|---|---|
| PEG | 34.09 |
| Price to Sales | 5.85 |
| Price to Book Ratio | 1.67 |
| Enterprise Value to Revenue | 4.24 |
| Enterprise Value to EBIT | -142.62 |
| Enterprise Value to Net Income | -24 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
ESG Score
No data
About Veracyte Inc
CEO: Bonnie Anderson